Genolution Inc. Total Liabilities

Latest as of September 2025: ₩26.44 Billion KRW ≈ $17.92 Million USD

Genolution Inc. total liabilities. Based on the latest financial reports, Genolution Inc. (225220) has total liabilities worth ₩26.44 Billion KRW (≈ $17.92 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 225220 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Genolution Inc. (2016–2024)

Total liabilities of Genolution Inc. from 2016 to 2024. This chart illustrates how Genolution Inc.'s total liabilities have evolved over time, based on quarterly financial data.

Genolution Inc. Competitors by Total Liabilities

The table below lists competitors of Genolution Inc. ranked by their total liabilities.

Company	Country	Total Liabilities
Beeline Holdings, Inc. NASDAQ:BLNE	USA	$19.35 Million
NanoViricides Inc NYSE MKT:NNVC	USA	$1.18 Million
Aarvi Encon Limited NSE:AARVI	India	Rs892.62 Million
Lung Hwa Electronics Co Ltd TW:2424	Taiwan	NT$145.44 Million
Hermana Holding ASA OL:HERMA	Norway	Nkr700.00K
Desoto Resources Ltd AU:DES	Australia	AU$462.95K
G11 Resources Ltd AU:G11	Australia	AU$408.92K
Anugerah Kagum Karya Utama Tbk PT JK:AKKU	Indonesia	Rp283.51 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Genolution Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 225220 current and non-current assets.

Liquidity & Leverage Metrics

Genolution Inc. Total Liabilities Ratios Explained

Genolution Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	5.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genolution Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genolution Inc. (2016–2024)

The table below shows the annual total liabilities of Genolution Inc. from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩26.16 Billion ≈ $17.73 Million	+0.68%
2023-12-31	₩25.99 Billion ≈ $17.61 Million	+31.55%
2022-12-31	₩19.75 Billion ≈ $13.39 Million	+55.08%
2021-12-31	₩12.74 Billion ≈ $8.63 Million	-43.34%
2020-12-31	₩22.48 Billion ≈ $15.24 Million	+108.37%
2019-12-31	₩10.79 Billion ≈ $7.31 Million	+32.26%
2018-12-31	₩8.16 Billion ≈ $5.53 Million	+1058.74%
2017-12-31	₩704.01 Million ≈ $477.10K	+23.38%
2016-12-31	₩570.62 Million ≈ $386.70K	--

About Genolution Inc.

KQ:225220 Korea Biotechnology

Market Cap

$21.55 Million

₩31.80 Billion KRW

Market Cap Rank

#24712 Global

#1783 in Korea

Share Price

₩1760.00

Change (1 day)

+1.21%

52-Week Range

₩1030.00 - ₩2225.00

All Time High

₩10300.23